Table 1 Baseline characteristics of patients.

From: Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

 

Cohort, n (%)

Inactivation, n (%)

No inactivation, n (%)

Patients

253

46 (18.2)

207 (81.8)

Sex

  Female

98 (38.7)

13 (28.3)

86 (41.5)

  Male

155 (61.3)

33 (71.7)

122 (58.5)

Age, median, years

5.88

6.32

5.86

1–9.9

165 (65.2)

31 (67.4)

134 (64.7)

10–17.9

54 (21.3)

12 (26)

42 (20.3)

18–45

34 (13.4)

3 (6.5)

31 (15.0)

Risk group

  SR

90 (35.6)

17 (37)

73 (35.3)

  IR-Low

63 (24.9)

11 (23.9)

52 (25.1)

  IR-High

80 (31.6)

15 (32.6)

65 (31.4)

  HR

19 (7.5)

3 (6.5)

16 (7.7)

  NAa

1

 

1

Immunophenotype

  B-cell ALL

227 (89.7)

43 (93.5)

184 (88.9)

  T-cell ALL

24 (9.5)

2 (4.3)

22 (10.6)

  Mixed

2 (0.8)

1 (2.2)

1 (0.5)

  1. aOne patient died before risk stratification.
Back to article page